Woodline Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Buy
73,108
+23,103
+46% +$1.86M 0.02% 661
2026
Q1
$4.33M Sell
50,005
-168,833
-77% -$16.2M 0.02% 682
2025
Q4
$21M Sell
218,838
-88,810
-29% -$8.63M 0.08% 302
2025
Q3
$29.3M Sell
307,648
-168,712
-35% -$15.5M 0.14% 205
2025
Q2
$41.5M Buy
476,360
+433,091
+1,001% +$36.7M 0.22% 131
2025
Q1
$3.89M Sell
43,269
-257,207
-86% -$23M 0.03% 565
2024
Q4
$24M Buy
+300,476
New +$26M 0.16% 180
2022
Q4
Sell
-944,872
Closed -$76.3M 812
2022
Q3
$76.3M Buy
944,872
+367,291
+64% +$33M 1.07% 8
2022
Q2
$51.8M Buy
+577,581
New +$58.5M 0.8% 19
2021
Q4
Sell
-359,728
Closed -$45.1M 755
2021
Q3
$45.1M Buy
+359,728
New +$46.6M 0.74% 27
2021
Q1
Sell
-586,448
Closed -$68.7M 457
2020
Q4
$68.7M Buy
586,448
+162,692
+38% +$17.9M 1.82% 9
2020
Q3
$44M Buy
+423,756
New +$42.6M 1.44% 17

Other funds holding MDT

Woodline Partners's MDT Position: Q2 2026 in Review

Woodline Partners increased its Medtronic (MDT) stake by 46% in Q2 2026, buying an estimated $1.86M and bringing the position to 73,108 shares worth $5.72M. The position accounts for 0.02% of the portfolio, ranked #661.

Woodline Partners first reported a position in MDT in Q3 2020 and has held it in 12 quarters since. The position peaked at $76.3M in Q3 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Woodline Partners held 73,108 shares of Medtronic worth $5.72M as of Q2 2026.
  • Woodline Partners bought 23,103 Medtronic shares in Q2 2026, an estimated $1.86M.
  • Medtronic made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #661 holding.
  • Woodline Partners first reported a position in Medtronic in Q3 2020 and has held it in 12 quarters since.
  • Woodline Partners's Medtronic position peaked at $76.3M in Q3 2022.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.